Idris Bahce

Amsterdam University Medical Centers

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

ITALY

View details

Mariana Brandão

Institut Jules Bordet

BELGIUM

View details

Dirk Pegtel

associate professor

VU medisch centrum

NETHERLANDS

View details

Birgit Lissenberg-Witte

Assistant professor

UMC Utrecht

NETHERLANDS

View details

Florent Mouliere

Group Leader / Assistant Professor

VU medisch centrum

NETHERLANDS

View details

Teodora Radonic

Amsterdam University Medical Centers

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Idris Bahce

Research Interests

Explore related searches

Contact this professor

Articles (10)

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study

Response to “Letter to Editor-in-Chief” and “Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management”

An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer

Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study

Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation

Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging

Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer

Collaborators (6)

Marco Tagliamento

Mariana Brandão

Dirk Pegtel

Birgit Lissenberg-Witte

Florent Mouliere

Teodora Radonic

Make your next move.